|
TXNDC15 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.64190000046172E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.68249999990644E-07 |
| Normal-vs-Stage2 |
2.056200E-03 |
| Normal-vs-Stage3 |
8.676800E-03 |
| Normal-vs-Stage4 |
1.986320E-04 |
| Stage1-vs-Stage2 |
6.563200E-01 |
| Stage1-vs-Stage3 |
4.717800E-01 |
| Stage1-vs-Stage4 |
6.475200E-01 |
| Stage2-vs-Stage3 |
8.645400E-01 |
| Stage2-vs-Stage4 |
4.895000E-01 |
| Stage3-vs-Stage4 |
4.568200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.95709999983862E-07 |
| Normal-vs-AfricanAmerican |
1.021980E-03 |
| Normal-vs-Asian |
4.612200E-02 |
| Caucasian-vs-AfricanAmerican |
3.093600E-01 |
| Caucasian-vs-Asian |
7.561600E-01 |
| AfricanAmerican-vs-Asian |
9.626000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.3436999835601E-09 |
| Normal-vs-Female |
1.700990E-01 |
| Male-vs-Female |
2.617700E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.82775999999496E-05 |
| Normal-vs-Extreme_Weight |
6.27140000042381E-07 |
| Normal-vs-Obese |
1.162750E-03 |
| Normal-vs-Extreme_Obese |
1.840480E-02 |
| Normal_Weight-vs-Extreme_Weight |
9.395400E-01 |
| Normal_Weight-vs-Obese |
3.003800E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.448400E-01 |
| Extreme_Weight-vs-Obese |
2.551600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.120800E-01 |
| Obese-vs-Extreme_Obese |
3.902200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.177400E-03 |
| Normal-vs-Age(41-60Yrs) |
9.617400E-04 |
| Normal-vs-Age(61-80Yrs) |
6.4428999912991E-09 |
| Normal-vs-Age(81-100Yrs) |
5.325900E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.082400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.868200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.986000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.179300E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.505200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.418400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.17320000001276E-07 |
| Normal-VS-Type2 PRCC |
2.86069999999583E-06 |
| Normal-VS-KIRP CIMP |
5.592100E-04 |
| Normal-VS-Unclassified PRCC |
4.885800E-02 |
| Type1 PRCC-VS-Type2 PRCC |
7.495200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
7.905600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.055800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.018600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.874180E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.349200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.79394999999527E-05 |
| Normal-vs-N1 |
5.239800E-02 |
| Normal-vs-N2 |
9.400000E-02 |
| N0-vs-N1 |
2.111400E-01 |
| N0-vs-N2 |
6.453200E-01 |
| N1-vs-N2 |
8.856800E-01 |
|
|
